Jeffrey A. Biskup is the President/CEO and founding principal partner of Clark, Richardson and Biskup Consulting Engineers, Inc. (CRB). Jeff received his BS in Mechanical Engineering from the University of Missouri in 1979, and has played a key role in developing CRB into a respected provider of architectural, engineering and construction related services for the life sciences industry. The firm has been ranked as one of the Top Five Pharmaceutical Engineering Firms in the U.S. by Engineering News and Record (ENR) and has held this honor for most of the past 10 years.
Biskup has been active with MOBIO since its inception and has been a contributor to numerous industry organizations like the International Society of Pharmaceutical Engineers (ISPE) and the Parenteral Drug Association. Jeff was instrumental in the development of the ISPE Baseline Guide to Biotech Facilities as well as other Baseline Guides. He is a frequent speaker at various national and international seminars and events in the biotech industry.
CRB was established in 1984 in Kansas City, Missouri and opened its St. Louis office in 1990. CRB currently employs over 450 professionals in 10 offices throughout the U.S. and Puerto Rico, more than 150 of those employees are located at Kansas City and St. Louis offices.
Today, CRB works with almost every major biotech company in the world. As a key service provider, CRB has been an important contributor to the success of such companies as Biogen Idec, J&J/Centocor, Pfizer, Amgen, Merck, Genentech, Novartis, Pfizer and others. CRB has worked extensively with Covidien, Pfizer, Sigma, Centocor, Boehringer Ingelheim Vetmedica, Monsanto and Stowers Institute for Medical Research, Kansas Bioscience Authority and Bayer Healthcare.